Bruce Zetter
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
Cell BiologyGoogle:
"Bruce Zetter"Children
Sign in to add trainee| Sonia W. Kim | grad student | 2004 | Harvard |
| Rachelle R. Olsen | grad student | 2011 | Harvard |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou K, Cheong JE, Tarakkad Krishnaji S, et al. (2022) Inhibition of Wnt signaling in colon cancer cells via an oral drug that facilitates TNIK degradation. Molecular Cancer Therapeutics |
| Chung I, Zhou K, Barrows C, et al. (2020) Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer. Frontiers in Oncology. 10: 594141 |
| Zhang J, Yin Y, Wang J, et al. (2020) Prohibitin regulates mTOR pathway via interaction with FKBP8. Frontiers of Medicine |
| Ghalali A, Stopsack KH, Rice JM, et al. (2020) Abstract 1822: RNA eding of AZIN1 increases cellular aggressiveness in prostate cancer Cancer Research. 80: 1822-1822 |
| Ghalali A, Rice JM, Wang L, et al. (2019) Abstract 4888: Nuclear localization of antizyme inhibitor may be a marker for aggressiveness of prostate cancer Cancer Research |
| Zhou K, Cheong JE, Zaffagni M, et al. (2019) Abstract 14: A new orally available drug for the treatment of metastatic cancers Cancer Research. 79: 14-14 |
| Islam MA, Xu Y, Tao W, et al. (2018) Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 850-864 |
| Sun L, Cheong JE, Zaffagni M, et al. (2018) Abstract 1670: Discovery of novel water-soluble derivatives of mebendazole as selective CLK1/4 kinase inhibitors and their anticancer cancer activity Cancer Research. 78: 1670-1670 |
| Cheong JE, Zaffagni M, Chung I, et al. (2017) Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry. 144: 372-385 |
| Islam MA, Xu Y, Zope H, et al. (2017) Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles. Journal of Clinical Oncology. 35: 11582-11582 |